Clinical Trial Update: Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma. [Phase 1]

View source ↗

Summary

Phase I trial evaluating the RNA oligonucleotide MTL-CEBPA in combination with atezolizumab and bevacizumab for advanced hepatocellular carcinoma; status is act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)
• MTL-CEBPA

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Advanced Hepatocellular Carcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING